Shopping Cart
- Remove All
Your shopping cart is currently empty
AChE-IN-62 (Compound 1) is a potent, mixed-type selective inhibitor of acetylcholinesterase (AChE) with an IC50 value of 0.421 μM. It effectively penetrates the blood-brain barrier and offers neuroprotective effects. Additionally, AChE-IN-62 inhibits the aggregation of Aβ1-42 with an IC50 of 44.64 μM. This compound also acts as an effective multi-target-directed ligand (MTDL) and is applicable in Alzheimer's disease research.

| Description | AChE-IN-62 (Compound 1) is a potent, mixed-type selective inhibitor of acetylcholinesterase (AChE) with an IC50 value of 0.421 μM. It effectively penetrates the blood-brain barrier and offers neuroprotective effects. Additionally, AChE-IN-62 inhibits the aggregation of Aβ1-42 with an IC50 of 44.64 μM. This compound also acts as an effective multi-target-directed ligand (MTDL) and is applicable in Alzheimer's disease research. |
| In vitro | AChE-IN-62 effectively inhibits the aggregation of Aβ 1−42 with an IC50 value of 44.64 μM when used at a concentration of 50 μM for 24-48 hours. Additionally, at concentrations ranging from 5-20 μM over 24 hours, AChE-IN-62 demonstrates neuroprotective properties by mitigating neurotoxicity mediated by H2O2 (200 μM; 24 h) and Okadaic acid (30 nM; 24 h) in SH-SY5Y and Neuro2A cells. |
| In vivo | AChE-IN-62 (Compound 1) at doses of 10-20 mg/kg, administered intraperitoneally once daily for 7 consecutive days, mitigates scopolamine-induced (3 mg/kg; intraperitoneal; once daily for 7 days) memory impairment and learning deficits in Swiss albino mice by repairing damage to the cerebral cortex and hippocampus, thereby offering neuroprotection against scopolamine-induced injuries. |
| Formula | C19H21N5O3S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.